- Olaparib combined with chemotherapy for recurrent platinum - sensitive ovarian cancer : a randomised phase 2trial2015 | Publication without faculty affiliation
- Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial2023 | First Faculty of Medicine
- Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial2015 | First Faculty of Medicine
- Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial2021 | First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
- Treatment of recurrent ovarian cancer2009 | Publication without faculty affiliation
- BRCA mutation carriers suffering from ovarian cancer as a model for treatment decision in higher lines - Place for platinum reinduction2023 | First Faculty of Medicine, Third Faculty of Medicine